Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1965 1
1966 2
1967 1
1968 5
1969 1
1970 7
1971 2
1972 4
1973 2
1974 7
1975 1
1976 1
1977 1
1978 8
1979 3
1980 2
1981 1
1982 3
1983 5
1984 13
1985 15
1986 10
1987 23
1988 29
1989 31
1990 30
1991 41
1992 44
1993 32
1994 40
1995 33
1996 38
1997 42
1998 34
1999 27
2000 36
2001 40
2002 44
2003 47
2004 38
2005 35
2006 33
2007 42
2008 43
2009 32
2010 46
2011 51
2012 51
2013 54
2014 59
2015 60
2016 50
2017 55
2018 62
2019 51
2020 68
2021 66
2022 62
2023 56
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

1,601 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric Brain Tumors.
Udaka YT, Packer RJ. Udaka YT, et al. Neurol Clin. 2018 Aug;36(3):533-556. doi: 10.1016/j.ncl.2018.04.009. Neurol Clin. 2018. PMID: 30072070 Review.
Medulloblastoma: WHO 2021 and Beyond.
Cotter JA, Hawkins C. Cotter JA, et al. Pediatr Dev Pathol. 2022 Jan-Feb;25(1):23-33. doi: 10.1177/10935266211018931. Pediatr Dev Pathol. 2022. PMID: 35168417 Review.
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O, Győrffy B. Menyhárt O, et al. Cancer Metastasis Rev. 2020 Mar;39(1):211-233. doi: 10.1007/s10555-020-09854-1. Cancer Metastasis Rev. 2020. PMID: 31970590 Free PMC article. Review.
Multimodal treatment consisting of surgery, radiation therapy, and chemotherapy reduced cumulative incidence of late mortality but increased the incidence of subsequent neoplasms and severe, incapacitating chronic health conditions. Present treatment strategies fail to rec …
Multimodal treatment consisting of surgery, radiation therapy, and chemotherapy reduced cumulative incidence of late mortality but increased …
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL. Ramaswamy V, et al. Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4. Acta Neuropathol. 2016. PMID: 27040285 Free PMC article. Review.
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stücklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P. Franceschi E, et al. Lancet Oncol. 2019 Dec;20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2. Lancet Oncol. 2019. PMID: 31797797 Review.
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. ...
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagn …
Development and cancer of the cerebellum.
Hatten ME, Roussel MF. Hatten ME, et al. Trends Neurosci. 2011 Mar;34(3):134-42. doi: 10.1016/j.tins.2011.01.002. Trends Neurosci. 2011. PMID: 21315459 Free PMC article. Review.
Medulloblastoma (MB) is the most common malignant pediatric brain tumor and is thought to arise from genetic anomalies in developmental pathways required for the normal maturation of the cerebellar cortex, notably developmental pathways for granule cell progenitor (GCP) ne …
Medulloblastoma (MB) is the most common malignant pediatric brain tumor and is thought to arise from genetic anomalies in developmental path …
Understanding medulloblastoma.
Quinlan A, Rizzolo D. Quinlan A, et al. JAAPA. 2017 Oct;30(10):30-36. doi: 10.1097/01.JAA.0000524717.71084.50. JAAPA. 2017. PMID: 28953021 Review.
Management of high-risk medulloblastoma.
Bouffet E. Bouffet E. Neurochirurgie. 2021 Feb;67(1):61-68. doi: 10.1016/j.neuchi.2019.05.007. Epub 2019 Jun 20. Neurochirurgie. 2021. PMID: 31229532 Review.
Cerebellar tumors.
Guerreiro Stucklin AS, Grotzer MA. Guerreiro Stucklin AS, et al. Handb Clin Neurol. 2018;155:289-299. doi: 10.1016/B978-0-444-64189-2.00019-6. Handb Clin Neurol. 2018. PMID: 29891066 Review.
The cerebellum is the most common site of presentation of central nervous system tumors in children but exceedingly rare in adults. ...The differential diagnosis is broad and includes a variety of benign and malignant entities. Cerebellar low-grade gliomas are the m …
The cerebellum is the most common site of presentation of central nervous system tumors in children but exceedingly rare in adults. . …
1,601 results